ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 242 filers reported holding ACCELERON PHARMA INC in Q3 2020. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $7,000 | +40.0% | 39 | -2.5% | 0.00% | – |
| Q2 2021 | $5,000 | 0.0% | 40 | 0.0% | 0.00% | – |
| Q1 2021 | $5,000 | -16.7% | 40 | -11.1% | 0.00% | -100.0% |
| Q4 2020 | $6,000 | -93.3% | 45 | -94.3% | 0.00% | -83.3% |
| Q3 2020 | $89,000 | -83.1% | 787 | -85.8% | 0.01% | -82.4% |
| Q2 2020 | $528,000 | +98.5% | 5,530 | +86.7% | 0.03% | +61.9% |
| Q1 2020 | $266,000 | +4333.3% | 2,962 | +2308.1% | 0.02% | – |
| Q1 2019 | $6,000 | -60.0% | 123 | -65.1% | 0.00% | -100.0% |
| Q4 2018 | $15,000 | +114.3% | 352 | +186.2% | 0.00% | 0.0% |
| Q3 2018 | $7,000 | -99.9% | 123 | -3.1% | 0.00% | 0.0% |
| Q2 2018 | $6,162,000 | +123140.0% | 127 | 0.0% | 0.00% | – |
| Q1 2018 | $5,000 | -50.0% | 127 | -45.0% | 0.00% | -100.0% |
| Q4 2017 | $10,000 | +66.7% | 231 | +36.7% | 0.00% | 0.0% |
| Q3 2017 | $6,000 | -25.0% | 169 | -33.5% | 0.00% | 0.0% |
| Q2 2017 | $8,000 | +14.3% | 254 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $7,000 | +16.7% | 254 | +2.4% | 0.00% | 0.0% |
| Q4 2016 | $6,000 | – | 248 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |